CHAPERONE TARGET INTERACTIONS

陪伴目标互动

基本信息

  • 批准号:
    7690594
  • 负责人:
  • 金额:
    $ 28.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-15 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

Copper is an essential element in eukaryotic organisms. Due to facile redox chemistry at moderate potentials, it functions at the active sites of many critical enzymes involved in a wide variety of processes, including neurotransmitter and neuropeptide hormone biosynthesis, biogenic amine metabolism and connective tissue formation, pigmentation, respiration, and antioxidant defense. New findings have linked certain cancers to copper mediated enzyme activity, for example the observation that the expression of the cuproenzyme PAM in endocrine tumors mediates tumor growth. Another intriguing link of importance to cancer therapy, is the recruitment of the CTR1 high affinity copper transporter in the uptake of cis-platin into cells by a presently unknown mechanism. Because copper is both essential and potentially toxic, cells have evolved complex molecular machinery to maintain levels within a narrow range of concentration, and failure to achieve liomeostasis results in diseases related to either Cu deficiency or excess which include those involving genetic mutations in the copper transporting ATPases, ATP7A (Menkes disease) and ATP7B (Wilson disease). Important consequences of aberrant copper homeostasis have also been implicated in neurodegenerative disorders, and in the pathology of amyloid plaque formation in Alzheimers. Therefore, the study of copper uptake, transport and trafficking is of great importance to human health. In eukaryotes, copper is imported by the membrane associated high affinity transporter CTR1, and thence distributed to target proteins via metallochaperone shuttles. An important tenet of copper homeostasis is the hypothesis that CTR1 hands off copper to the chaperones which in turn transport the metal to its sites of action. However, the interaction of CTR1 with chaperones has not yet been experimentally verified. Project 2 of the PPG will therefore leverage recent advances in the structural biology of hCTRl to investigate (i) the mode of copper binding to CTR1, (ii) the interaction of CTR1 with the chaperone hCCS, and (iii) the mechanisms by which chaperones and ATPases interact with and transfer copper to their target cuproenzymes. The technique of selenium-labeling coupled to X-ray absorption spectroscopy (developed in the last grant period) will be used extensively in these studies.
铜是真核生物的必需元素。由于在中等电位下容易发生氧化还原化学反应, 在涉及多种过程的许多关键酶的活性位点发挥功能,包括 神经递质和神经肽激素生物合成、生物胺代谢和结缔组织 形成、色素沉着、呼吸和抗氧化防御。新发现将某些癌症与 铜介导的酶活性,例如观察到铜酶 PAM 的表达 内分泌肿瘤介导肿瘤生长。癌症治疗的另一个重要的有趣联系是 CTR1高亲和力铜转运蛋白在细胞摄取顺铂过程中的募集 未知的机制。由于铜既是必需的又具有潜在的毒性,因此细胞进化出了复杂的 分子机械将水平维持在狭窄的浓度范围内,并且未能实现 脂质平衡会导致与铜缺乏或过量相关的疾病,其中包括那些涉及遗传的疾病 铜转运 ATP 酶、ATP7A(门克斯病)和 ATP7B(威尔逊病)发生突变。 铜稳态异常的重要后果也与神经退行性疾病有关 疾病,以及阿尔茨海默病中淀粉样蛋白斑形成的病理学。因此,铜的研究 摄取、运输和贩运对人类健康非常重要。在真核生物中,铜的输入方式是 膜相关的高亲和力转运蛋白 CTR1,然后通过 金属伴侣穿梭。铜稳态的一个重要原则是 CTR1 传递的假设 将铜结合到分子伴侣上,分子伴侣又将金属转运到其作用位点。然而,相互作用 带有伴侣的 CTR1 尚未经过实验验证。因此,PPG 的项目 2 将利用 hCTR1 结构生物学的最新进展,以研究 (i) 铜与 CTR1 结合的模式,(ii) CTR1 与伴侣 hCCS 的相互作用,以及 (iii) 伴侣和 ATP 酶的机制 与目标铜酶相互作用并将铜转移至目标铜酶。硒标记技术与 X 射线吸收光谱(在最后资助期间开发)将广泛用于这些研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ninian J Blackburn其他文献

Ninian J Blackburn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ninian J Blackburn', 18)}}的其他基金

Mechanisms of Copper Transport and Catalysis
铜的传输和催化机制
  • 批准号:
    10610381
  • 财政年份:
    2020
  • 资助金额:
    $ 28.86万
  • 项目类别:
Mechanisms of Copper Transport and Catalysis
铜的传输和催化机制
  • 批准号:
    10397998
  • 财政年份:
    2020
  • 资助金额:
    $ 28.86万
  • 项目类别:
Tracking Metal Flux Through a Pathogenic Export Complex
通过致病性出口复合物追踪金属通量
  • 批准号:
    9331067
  • 财政年份:
    2017
  • 资助金额:
    $ 28.86万
  • 项目类别:
XAS STUDIES OF METAL TRANSFER
金属转移的 XAS 研究
  • 批准号:
    8362237
  • 财政年份:
    2011
  • 资助金额:
    $ 28.86万
  • 项目类别:
XAS STUDIES OF METAL TRANSFER
金属转移的 XAS 研究
  • 批准号:
    8170197
  • 财政年份:
    2010
  • 资助金额:
    $ 28.86万
  • 项目类别:
XAS STUDIES OF HEME-COPPER ASSEMBLY PROTEINS
血红素-铜组装蛋白的 XAS 研究
  • 批准号:
    8169979
  • 财政年份:
    2010
  • 资助金额:
    $ 28.86万
  • 项目类别:
XAS STUDIES OF HEME-COPPER ASSEMBLY PROTEINS
血红素-铜组装蛋白的 XAS 研究
  • 批准号:
    7954260
  • 财政年份:
    2009
  • 资助金额:
    $ 28.86万
  • 项目类别:
XAS STUDIES OF METAL TRANSFER
金属转移的 XAS 研究
  • 批准号:
    7954542
  • 财政年份:
    2009
  • 资助金额:
    $ 28.86万
  • 项目类别:
XAS STUDIES OF COPPER MONOOXYGENASE ENZYMES
铜单加氧酶的 XAS 研究
  • 批准号:
    7954249
  • 财政年份:
    2009
  • 资助金额:
    $ 28.86万
  • 项目类别:
XAS STUDIES OF HEME-COPPER ASSEMBLY PROTEINS
血红素-铜组装蛋白的 XAS 研究
  • 批准号:
    7721908
  • 财政年份:
    2008
  • 资助金额:
    $ 28.86万
  • 项目类别:

相似海外基金

Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334970
  • 财政年份:
    2024
  • 资助金额:
    $ 28.86万
  • 项目类别:
    Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
  • 批准号:
    2400195
  • 财政年份:
    2024
  • 资助金额:
    $ 28.86万
  • 项目类别:
    Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334969
  • 财政年份:
    2024
  • 资助金额:
    $ 28.86万
  • 项目类别:
    Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
  • 批准号:
    23K04919
  • 财政年份:
    2023
  • 资助金额:
    $ 28.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
  • 批准号:
    22KJ2957
  • 财政年份:
    2023
  • 资助金额:
    $ 28.86万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
  • 批准号:
    23K04494
  • 财政年份:
    2023
  • 资助金额:
    $ 28.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
  • 批准号:
    23K13831
  • 财政年份:
    2023
  • 资助金额:
    $ 28.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
  • 批准号:
    2238379
  • 财政年份:
    2023
  • 资助金额:
    $ 28.86万
  • 项目类别:
    Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
  • 批准号:
    2154399
  • 财政年份:
    2022
  • 资助金额:
    $ 28.86万
  • 项目类别:
    Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
  • 批准号:
    RGPIN-2019-06633
  • 财政年份:
    2022
  • 资助金额:
    $ 28.86万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了